» Articles » PMID: 35722260

Association Between Chronic Kidney Disease and Mortality in Patients with a Confirmed COVID-19 Diagnosis

Overview
Journal PeerJ
Date 2022 Jun 20
PMID 35722260
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the association between chronic kidney disease (CKD) and mortality in persons with a confirmed coronavirus disease 2019 (COVID-19) diagnosis.

Methods: Cross-sectional secondary baseline study. The study population consisted of 243,065 patients confirmed to have COVID-19 during May-December 2020. Stata 16.0 was used for statistical analysis, Chi-square test was used for bivariate analysis, and Poisson regression with robust variances was used for multiple analysis.

Results: The prevalence of patients with a confirmed COVID-19 diagnosis who had CKD and died was 1.42 times the prevalence of mortality in those without CKD. The comorbidities combined with CKD that presented the highest probability of mortality were diabetes mellitus and hypertension.

Conclusions: CKD is associated with a high mortality rate in patients with a confirmed COVID-19 diagnosis. Patients with CKD, diabetes mellitus, and arterial hypertension have a higher prevalence of mortality than those without comorbidities.

Citing Articles

Predictors of mortality in hospitalised patients with COVID-19: a 1-year case-control study.

Camacho-Dominguez L, Rojas M, Herran M, Rodriguez Y, Beltran S, Galindo P BMJ Open. 2024; 14(2):e072784.

PMID: 38355186 PMC: 10868294. DOI: 10.1136/bmjopen-2023-072784.


COVID-19 and chronic kidney disease: a bibliometric analysis.

Jiang W, Chen Y, Zhao Y, Gao Y, Cheng T, Qian E Ann Med Surg (Lond). 2024; 86(1):336-344.

PMID: 38222697 PMC: 10783392. DOI: 10.1097/MS9.0000000000001640.

References
1.
Callender L, Curran M, Bates S, Mairesse M, Weigandt J, Betts C . The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Front Immunol. 2020; 11:1991. PMC: 7437504. DOI: 10.3389/fimmu.2020.01991. View

2.
Sellares V . Usefulness of urinary parameters in advanced chronic kidney disease. Nefrologia (Engl Ed). 2018; 39(2):124-132. DOI: 10.1016/j.nefro.2018.06.008. View

3.
Martos-Benitez F, Soler-Morejon C, Garcia-Del Barco D . Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico. Intern Emerg Med. 2021; 16(6):1507-1517. PMC: 7788175. DOI: 10.1007/s11739-020-02597-5. View

4.
Gonzalez-Castro A, Escudero-Acha P, Penasco Y, Leizaola O, Martinez de Pinillos Sanchez V, Garcia de Lorenzo A . [Intensive care during the 2019-coronavirus epidemic]. Med Intensiva. 2024; 44(6):351-362. PMC: 7271070. DOI: 10.1016/j.medin.2020.03.001. View

5.
DMarco L, Puchades M, Romero-Parra M, Gimenez-Civera E, Soler M, Ortiz A . Coronavirus disease 2019 in chronic kidney disease. Clin Kidney J. 2020; 13(3):297-306. PMC: 7367105. DOI: 10.1093/ckj/sfaa104. View